Skip to Content
Merck
CN
  • The anticancer mechanism of caffeic acid phenethyl ester (CAPE): review of melanomas, lung and prostate cancers.

The anticancer mechanism of caffeic acid phenethyl ester (CAPE): review of melanomas, lung and prostate cancers.

European review for medical and pharmacological sciences (2013-01-03)
G Ozturk, Z Ginis, S Akyol, G Erden, A Gurel, O Akyol
ABSTRACT

Caffeic acid phenethyl ester (CAPE), an active component of propolis extract, specifically inhibits NF-κB. It exhibits antioxidant, antiinflammatory, antiproliferative, cytostatic, and most importantly, antineoplastic properties. The aim of the present mini-review is to summarize and evaluate the anticancer mechanism of CAPE with examples of several cancer types. In view of the mechanisms and findings in our laboratory and those of others in literature, we suggest that CAPE possess anticancer and apoptosis inducing activities. Further researches are needed regarding the anticancer basis of CAPE in all disciplines of medicine. Also, clinical potential toxicities of CAPE should be revealed if it is going to be used as an anticancer agent.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Caffeic acid phenethyl ester, ≥97% (HPLC), powder
Sigma-Aldrich
2-Phenylethanol, ≥99.0% (GC)
Supelco
Phenylethyl Alcohol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Phenethyl alcohol, ≥99%, FCC, FG
Sigma-Aldrich
Phenethyl alcohol, natural, ≥99%, FCC, FG